Kaneka maintenance and supply Dallas VA

VA Dallas Healthcare System Research Department intends to negotiate on a sole source basis with Kaneka Pharma America, pursuant to FAR 6.302-1. This request for Other than Full and Open Competition is for the procurement of a new, Firm, Fixed Price contract with Kaneka for services related to the maintenance of four LA-15 Apheresis Systems currently being utilized at Dallas Veterans of Affairs Medical Center and Oklahoma City VA Medical Center in support of the PREMIER CCTA0002 study pertaining to cholesterol reduction treatment. The VA Dallas had a previous contract with Kaneka supporting this research study and continued utilization is required to ensure continuity of data. This notice of intent is not a request for competitive proposals; however, any responsible source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than Wednesday, May 17, 2017, 4:00, EST. Interest/capability statements may be sent to Elaine DiBucci at elaine.dibucci@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.